AJCN Cancer Health Disparities Conference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Bao, Y.
Right arrow Articles by Michaud, D. S
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bao, Y.
Right arrow Articles by Michaud, D. S
Agricola
Right arrow Articles by Bao, Y.
Right arrow Articles by Michaud, D. S
American Journal of Clinical Nutrition, Vol. 88, No. 2, 431-440, August 2008
© 2008 American Society for Nutrition


ORIGINAL RESEARCH COMMUNICATION

Added sugar and sugar-sweetened foods and beverages and the risk of pancreatic cancer in the National Institutes of Health–AARP Diet and Health Study1,2,3

Ying Bao, Rachael Stolzenberg-Solomon, Li Jiao, Debra T Silverman, Amy F Subar, Yikyung Park, Michael F Leitzmann, Albert Hollenbeck, Arthur Schatzkin and Dominique S Michaud

1 From the Department of Epidemiology, Harvard School of Public Health, Boston, MA (YB and DSM); the Divisions of Cancer Epidemiology and Genetics (RSS, LJ, DTS, YP, MFL, AS, and DSM) and Cancer Control and Population Sciences (AFS), National Cancer Institute, Rockville, MD; AARP, Washington, DC (AH); and the Department of Epidemiology and Public Health, Imperial College London, United Kingdom (DSM)

Background: Although it has been hypothesized that hyperglycemia, hyperinsulinemia, and insulin resistance are involved in the development of pancreatic cancer, results from epidemiologic studies of added sugar intake are inconclusive.

Objective: Our objective was to investigate whether the consumption of total added sugar and sugar-sweetened foods and beverages is associated with pancreatic cancer risk.

Design: In 1995 and 1996, we prospectively examined 487 922 men and women aged 50–71 y and free of cancer and diabetes. Total added dietary sugar intake (in tsp/d; based on the US Department of Agriculture's Pyramid Servings Database) was assessed with a food-frequency questionnaire. Relative risks (RRs) and 95% CIs were calculated with adjustment for total energy and potential confounding factors.

Results: During an average 7.2 y of follow-up, 1258 incident pancreatic cancer cases were ascertained. The median intakes for the lowest and highest quintiles of total added sugar intake were 12.6 (3 tsp/d) and 96.2 (22.9 tsp/d) g/d, respectively. No overall greater risk of pancreatic cancer was observed in men or women with high intake of total added sugar or sugar-sweetened foods and beverages. For men and women combined, the multivariate RRs of the highest versus lowest intake categories were 0.85 (95% CI: 0.68, 1.06; P for trend = 0.07) for total added sugar, 1.01 (0.82,1.23; P for trend = 0.58) for sweets, 0.98 (0.82,1.18; P for trend = 0.49) for dairy desserts, 1.12 (0.91,1.39; P for trend = 0.35) for sugar added to coffee and tea, and 1.01 (0.77,1.31; P for trend = 0.76) for regular soft drinks.

Conclusion: Our results do not support the hypothesis that consumption of added sugar or of sugar-sweetened foods and beverages is associated with overall risk of pancreatic cancer.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The American Society for Nutrition